Live feed07:00:00·4mPRReleasevia QuantisnowTalawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I DiseasesByQuantisnow·Wall Street's wire, on your screen.JATT· JATT II Acquisition Corp